Mardiak, Jozef

Prognostic Value of Programmed-Death-1 Receptor (PD-1) and Its Ligand 1 (PD-L1) in Testicular Germ Cell Tumors

Cierna, Z., Mego, M., Miskovska, V., Machalekova, K., Chovanec, M., Svetlovska, D., Hainova, K., Rejlekova, K., Macak, D., Spanik, S., et al. (2016) · Annals of Oncology

Testicular diseases and treatmentsCancer Immunotherapy and Biomarkers

Cited by 162

Systemic immune-inflammation index in germ-cell tumours

Chovanec, M., Cierna, Z., Miskovska, V., Machalekova, K., Kalavska, K., Rejlekova, K., Svetlovska, D., Macak, D., Spanik, S., Kajo, K., et al. (2018) · British Journal of Cancer

Inflammatory Biomarkers in Disease PrognosisTesticular diseases and treatments

Cited by 90

Phase II Study of Avelumab in Multiple Relapsed/Refractory Germ Cell Cancer

Mego, M., Svetlovska, D., Chovanec, M., Rečkova, M., Rejlekova, K., Obertova, J., Palacka, P., Sycova-Mila, Z., De Giorgi, U., & Mardiak, J. (2019) · Investigational New Drugs

Testicular diseases and treatmentsCancer Immunotherapy and Biomarkers

Cited by 81

Prognostic role of programmed-death ligand 1 (PD-L1) expressing tumor infiltrating lymphocytes in testicular germ cell tumors

Chovanec, M., Cierna, Z., Miskovska, V., Machalekova, K., Svetlovska, D., Kalavska, K., Rejlekova, K., Spanik, S., Kajo, K., Babal, P., et al. (2017) · Oncotarget

Cancer Immunotherapy and BiomarkersTesticular diseases and treatments

Cited by 79

A Cytokine and Angiogenic Factor (CAF) Analysis in Plasma in Testicular Germ Cell Tumor Patients (TGCTs)

Chovanec, M., Mego, M., Cholujova, D., Gronesova, P., Miskovska, V., Sycova-Mila, Z., Usakova, V., Svetlovska, D., Bujdak, P., Spanik, S., et al. (2015) · Journal of Clinical Oncology

Testicular diseases and treatmentsInflammatory Biomarkers in Disease Prognosis

Cited by 6